1 |
GALDOS F X, GUO Y X, PAIGE S L, et al. Cardiac regeneration: lessons from development[J]. Circ Res, 2017, 120(6): 941-959.
|
2 |
PETERSON V R, NORTON G R, MADZIVA M T, et al. Metformin prevents low-dose isoproterenol-induced cardiac dilatation and systolic dysfunction in male sprague dawley rats[J]. J Cardiovasc Pharmacol, 2022, 79(3): 289-295.
|
3 |
HUANG K Y, QUE J Q, HU Z S, et al. Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury[J]. Int J Biol Sci, 2020, 16(14): 2559-2579.
|
4 |
SMOLICH J J. Ultrastructural and functional features of the developing mammalian heart: a brief overview[J]. Reprod Fertil Dev, 1995, 7(3): 451-461.
|
5 |
PARK J, CHOI H, MIN J S, et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells[J]. J Neurochem, 2013, 127(2): 221-232.
|
6 |
VAN HORSSEN J, VAN SCHAIK P, WITTE M. Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?[J]. Neurosci Lett, 2019, 710: 132931.
|
7 |
VEZZANI B, CARINCI M, PATERGNANI S, et al. The dichotomous role of inflammation in the CNS: a mitochondrial point of view[J]. Biomolecules, 2020, 10(10): 1437.
|
8 |
IKEDA Y, SHIRAKABE A, BRADY C, et al. Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system[J]. J Mol Cell Cardiol, 2015, 78: 116-122.
|
9 |
ROSSI A, PIZZO P, CalciumFILADI R,et al. mitochondria and cell metabolism: a functional triangle in bioenergetics[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(7): 1068-1078.
|
10 |
DING M G, LIU C Y, SHI R, et al. Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1-dependent way[J].Acta Physiol (Oxf), 2020, 229(1): e13428.
|
11 |
DE MARAÑÓN A M, CANET F, ABAD-JIMÉNEZ Z, et al. Does metformin modulate mitochondrial dynamics and function in type 2 diabetic patients?[J]. Antioxid Redox Signal, 2021, 35(5): 377-385.
|
12 |
PALEE S, HIGGINS L, LEECH T, et al. Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia/reperfusion injury[J]. Biomedecine Pharmacother, 2020, 130: 110604.
|
13 |
TSAI C Y, KUO W W, SHIBU M A,et al. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling[J]. PLoS One, 2017, 12(9): e0184153.
|
14 |
OLDFIELD C J, DUHAMEL T A, DHALLA N S. Mechanisms for the transition from physiological to pathological cardiac hypertrophy[J]. Can J Physiol Pharmacol, 2020, 98(2): 74-84.
|
15 |
THAM Y K, BERNARDO B C, OOI J Y, et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets[J]. Arch Toxicol, 2015, 89(9): 1401-1438.
|
16 |
PEOPLES J N, SARAF A, GHAZAL N, et al. Mitochondrial dysfunction and oxidative stress in heart disease[J]. Exp Mol Med, 2019, 51(12): 1-13.
|
17 |
CHISTIAKOV D A, SHKURAT T P, MELNICHENKO A A, et al. The role of mitochondrial dysfunction in cardiovascular disease: a brief review[J]. Ann Med, 2018, 50(2): 121-127.
|
18 |
PENG W X, CAI G D, XIA Y P, et al. Mitochondrial dysfunction in atherosclerosis[J]. DNA Cell Biol, 2019, 38(7): 597-606.
|
19 |
CHEN Y T, CHANG Y, ZHANG N J, et al. Atorvastatin attenuates myocardial hypertrophy in spontaneously hypertensive rats via the C/EBPβ/PGC-1α/UCP3 pathway[J]. Cell Physiol Biochem, 2018, 46(3): 1009-1018.
|
20 |
DI NOTTIA M, VERRIGNI D, TORRACO A, et al. Mitochondrial dynamics: molecular mechanisms, related primary mitochondrial disorders and therapeutic approaches[J]. Genes (Basel), 2021, 12(2): 247.
|
21 |
TILOKANI L, NAGASHIMA S, PAUPE V, et al. Mitochondrial dynamics: overview of molecular mechanisms[J].Essays Biochem,2018, 62(3): 341-360.
|
22 |
TAN Y, XIA F F, LI L L, et al. Novel insights into the molecular features and regulatory mechanisms of mitochondrial dynamic disorder in the pathogenesis of cardiovascular disease[J]. Oxid Med Cell Longev, 2021, 2021: 6669075.
|
23 |
KUMAR R, BUKOWSKI M J, WIDER J M, et al. Mitochondrial dynamics following global cerebral ischemia[J]. Mol Cell Neurosci, 2016, 76: 68-75.
|
24 |
YAMAGUCHI R, LARTIGUE L, PERKINS G,et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization[J].Mol Cell,2008,31(4): 557-569.
|
25 |
NIIZUMA K, YOSHIOKA H, CHEN H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia[J]. Biochim Biophys Acta, 2010, 1802(1): 92-99.
|
26 |
CHAN D C. Mitochondrial dynamics and its involvement in disease[J]. Annu Rev Pathol, 2020, 15: 235-259.
|
27 |
FLANNERY P J, TRUSHINA E. Mitochondrial dynamics and transport in Alzheimer’s disease[J]. Mol Cell Neurosci, 2019, 98: 109-120.
|
28 |
NAN J L, ZHU W, RAHMAN M S,et al. Molecular regulation of mitochondrial dynamics in cardiac disease[J]. Biochim Biophys Acta BBA Mol Cell Res, 2017, 1864(7): 1260-1273.
|
29 |
DING J, ZHANG Z H, LI S, et al. Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-Activated mitochondrial fission and oxidative stress[J]. Arch Biochem Biophys, 2022, 718: 109147.
|
30 |
LIU C, HAN Y, GU X,et al. Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy[J]. Redox Biol, 2021, 46: 102098.
|
31 |
BENES J, KOTRC M, KROUPOVA K, et al. Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)[J]. Sci Rep, 2022, 12(1): 13038.
|